EIF2A and Sepsis: HMB is known to prevent phosphorylation of eiF2α [31] and may thereby block the early sepsis induced reductions in protein synthesis, but, theoretically, this action should not be effective in improving muscle function if HMB is given well after muscle weakness has developed.